Tabakrauchen und Krebsrisiko

Bis zu 30 % der Krebstodesfälle in Deutschland können auf das Rauchen zurückgeführt werden. Wird Tabakrauch kombiniert mit Alkohol, vervielfacht sich das Krebsrisiko, und dies kann zu zahlreichen tabakrauchassoziierten Malignomen führen. Mit GKV-Krebsfrüherkennungsmaßnahmen, Aufklärung und professioneller Unterstützung für Betroffene, mit dem Rauchen aufzuhören, kann das tabakbedingte Krebsrisiko effektiv gesenkt werden.

Abstract

Smoking tobacco is the most important and potentially modifiable risk factor for cancer in Germany. Combining tobacco with alcohol can multiply cancer risks. Up to 30 % of cancer deaths are due to tobacco smoking. 23,3 % of 18–64 year-old Germans are current smokers; in addition, 11 % of the population are regularly exposed to secondhand tobacco smoke. Tobacco smoking is causally associated with oropharyngeal, laryngeal, nose, paranasal sinus, lung, esophageal, gastric, pancreatic, hepatocellular, biliary, colorectal, kidney, ureter, urinary bladder, uterine cervix and ovary cancers and leukemia. Smokers should be encouraged to stop smoking and join programmes of cancer screening. Smoking cessation effectively reduces tobacco-associated cancer risk.

Schlüsselwörter

Rauchen - Tabak - Malignom - Krebs - Tumor - Neoplasie - Mund - Rachen - Kehlkopf - Nase - Nebenhöhlen - Lunge - Ösophagus - Magen - Pankreas - Leber - Darm - Harnblase - Harnleiter - Niere - Zervix - Eierstock - Leukämie

Key words

smoking - tumor - neoplasm - head and neck carcinoma - lung - esophagus - stomach - pancreas - liver - bile duct - colorectal - ovary - uterine cervix, - kidney - ureter - urinary bladder - leukemia

Publication History

Article published online:
18 March 2021

• Literatur

• 1 Dagenais GR, Leong DP, Rangarajan S. et al. Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study. Lancet 2020; 395: 785-794
• 2 Kindler-Röhrborn A. Krebsrisiko: Bei Frauen und Männern unterschiedlich ausgeprägt. Dtsch Arztebl 2020; 117 (11) 12
• 3 Mons U, Gredner T, Behrends G. et al. Cancers due to smoking and high alcohol consumption – estimation of the attributable cancer burden in Germany. Dtsch Arztebl Int 2018; 115: 571-577
• 4 Mons U, Kahnert S. Neuberechnung der tabakattributablen Mortalität – Nationale und regionale Daten für Deutschland. Gesundheitswesen 2019; 81: 24-33
• 5 Henley SJ, Thomas CC, Sharapova SR. et al. Vital Signs: Disparities in Tobacco-Related Cancer Incidence and Mortality – United States, 2004–2013. Morb Mortal Wkly Rep 2016; 65 (44) 1212-1218
• 6 Agudo A, Bonet C, Travier N. et al. Impact of cigarette smoking on cancer risk in the European prospective investigation into cancer and nutrition study. J Clin Oncol 2012; 30 (36) 4550-4557
• 7 US Department of Health and Human Services. Smoking Cessation. A Report of the Surgeon General. Im Internet (Stand: 09.10.2020): https://www.hhs.gov/sites/default/files/2020-cessation-sgr-full-report.pdf
• 8 Kuntz B. et al Tabak – Zahlen und Fakten zum Konsum. In: Deutsche Hauptstelle für Suchtfragen (Hrsg). DHS Jahrbuch Sucht 2020 Lengerich: Pabst Science Publishers; 2020
• 9 Atzendorf J, Rauschert C, Seitz NN. et al. The Use of Alcohol, Tobacco, Illegal Drugs and Medicines. Dtsch Arztebl Int 2019; 116: 577-584
• 10 Mravec B, Tibensky M, Horvathova L. et al. E-Cigarettes and Cancer Risk. Cancer Prev Res (Phila) 2020; 13: 137-144
• 11 Watermann I, Reck M. CT-Screening beim Lungenkarzinom – wie ist die Evidenz?. TumorDiagn u Ther 2020; 41: 171-173
• 12 De Koning H, Van der Aalst C, de Jong PA. et al. Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial. N Engl J Med 2020; 382 (06) 503-513
• 13 Dal Maso L, Torelli N, Biancotto E. et al. Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models. Eur J Epidemiol 2016; 31: 385-393
• 14 Scherübl H, Cataldegirmen G, Eick J. et al. Field cancerization of the upper aerodigestive tract: Screening for second primary esophageal cancers in cancer survivors. EMJ Oncol 2015; 3: 21-28
• 15 Brenner H, Arndt V, Bode G. et al. Risk of gastric Cancer Among Smokers Infected With Helicobacter Pylori. Int J Cancer 2002; 98: 446-449
• 16 Buckland G, Travier N, Huerta JM. et al. Healthy lifestyle index and risk of gastric adenocarcinoma in the EPIC cohort study. Int J Cancer 2015; 137 (03) 598-606
• 17 Jun JK, Choi KS, Lee HY. et al. Effectiveness of the Korean National Cancer Screening Program in Reducing Gastric Cancer Mortality. Gastroenterology 2017; 152 (06) 1319-1328
• 18 Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol 2019; 16: 713-732
• 19 Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ 2014; 348: g2467
• 20 Sung H, Siegel R, Rosenberg P. et al. Emerging cancer trends among young adults in the USA: analysis of a populationbased cancer registry. Lancet Public Health 2019; 4: e137-e147
• 21 Vuik F, Nieuwenburg S, Bardou M. et al. Increasing incidence of colorectal cancer in young adults in Europe over the last 25 years. Gut 2019; 68: 1820-1826
• 22 Baecker A, Liu X, La Vecchia C. et al. Worldwide incidence of hepatocellular carcinoma cases attributable to major risk factors. Eur J Cancer Prev 2018; 27 (03) 205-212
• 23 Chuang SC, Lee YC, Hashibe M. et al. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2010; 19 (05) 1261-1268
• 24 Meyer J, Rohrmann S, Bopp M. et al. Swiss National Cohort Study Group. Impact of Smoking and Excess Body Weight on Overall and Site-Specific Cancer Mortality Risk. Cancer Epidemiol Biomarkers Prev 2015; 24 (10) 1516-1522
• 25 Parkin DM, Boyd L, Walker LC. The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010. Br J Cancer 2011; 105 (Suppl. 02) S77-S81
• 26 Molina-Montes E, Van Hoogstraten L, Gomez-Rubio P. et al. Pancreatic Cancer Risk in Relation to Lifetime Smoking Patterns, Tobacco Type, and Dose-Response Relationships. Cancer Epidemiol Biomarkers Prev 2020; 29 (05) 1009-1018
• 27 Pietzak EJ, Mucksavage P, Guzzo TJ. et al. Heavy Cigarette Smoking and Aggressive Bladder Cancer at Initial Presentation. Urology 2015; 86: 968-972